Growblox Sciences Inc Stock Other OTC
Equities
US3998471029
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.83M 9.34M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -4M -5.48M | EV / Sales 2022 | - |
Net Debt 2022 | 1.15M 1.58M | Net Debt 2023 | 1.29M 1.76M | EV / Sales 2023 | - |
P/E ratio 2022 |
-16.8
x | P/E ratio 2023 |
-1.56
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.78% |
Managers | Title | Age | Since |
---|---|---|---|
John Poss
CEO | Chief Executive Officer | 76 | 15-07-26 |
President | 54 | 14-06-09 | |
Monica Poss
PRN | Corporate Officer/Principal | - | 18-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
President | 54 | 14-06-09 | |
John Poss
CEO | Chief Executive Officer | 76 | 15-07-26 |
1st Jan change | Capi. | |
---|---|---|
+25.23% | 46.56B | |
+45.38% | 41.67B | |
+0.16% | 41.16B | |
+33.42% | 32.4B | |
+21.08% | 28.18B | |
-6.35% | 28.1B | |
+49.02% | 14.52B | |
+47.52% | 13.74B | |
+3.27% | 12.17B |